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ABSTRACT
Advances in surgical and anesthetic techniques associated with 
closer perioperative monitoring appear to allow non-cardiac elective 
surgical procedures possible with acceptable risk in patients with 
severe aortic stenosis. A correct diagnosis of the severity of aortic 
stenosis is mandatory in preoperative evaluation of these patients. 
Recent published data suggest that at least for “asymptomatic 
severe aortic stenosis” patients with preserved LV systolic function 
and no other significant valvular pathology, a reappraisal of the 
grading of the severity of AS in general and reassessment of 
perioperative risk during elective non-cardiac surgery is needed.
© 2016 The Author. Published by ACT Publishing Group Ltd.
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INTRODUCTION 
Aortic stenosis has become the most frequent type of valvular 
heart disease in Europe and North America in relation to the 
increased life expectancy in elderly population. Data from Euro 
Heart Survey on Valvular Heart Disease suggest that moderate 
to severe degenerative calcific aortic stenosis affects 2-3% of 
patients aged > 65 years and 7-10% aged > 80 year[1]. The need for 
non-cardiac surgery (NCS) in patients with aortic stenosis (AS) 
increased significantly in the last two decades. These patients are at 
high risk of major cardiovascular events or death in perioperative 
period, therefore, in the case of elective interventions, guidelines 
suggest deferral of non-cardiac surgery after valve replacement[2,3]. 
Not uncommonly however patients with untreated aortic stenosis 
undergo non-cardiac surgery. The main cause of non adherence to 
guidelines are asymptomatic cardiac status, patient refusal to valve 
replacement, urgency- emergency of non-cardiac surgery and finally 
prohibitive risk arising from the cardiac surgery related to multiple 
patient comorbidities[4]. In patients with known aortic valve disease, 
since disease progression is highly variable, a careful clinical and 
echocardiographic evaluation must be obtained closely to surgical 
procedure. 
PATHOPHYSIOLOGY 
Severe AS (defined as aortic valve area < 1 cm2, 0.6 cm2/m2 body 
surface area) has been reported a high risk factor for perioperative 
myocardial infarction and cardiovascular mortality in patients 
undergoing non-cardiac surgery[5]. In aortic stenosis as long as 
the increase of left ventricular wall thickness allows to maintain a 
normal wall stress, ejection fraction is preserved.
    However, if the hypertrophic process is inadequate and relative 
wall thickness does not increase in proportion to pressure, wall 
stress increases and ejection fraction falls due to increased afterload. 
Primitive depression of myocardial function may occur in in natural 
history of aortic stenosis. The differential diagnosis between these 
two conditions is often clinically difficult. Hemodynamic demands 
related to non-cardiac surgery in AS patients may be not coped due 
to limited capability of left ventricle to increase stroke volume in 
the presence of critically decreased aortic valve area. Hypotension 
related to inappropriate blood loss and/or spinal anaesthesia, 
which may cause an uncontrollable decrease in systemic vascular 
resistance may be detrimental in these patients. Moreover it must be 
stressed that a significant coronary artery disease has been reported 
in about 50% of patients with severe aortic stenosis. Decreased 
diastolic coronary flow may be critical, in particular in patients 
with coronary artery disease, leading to severe myocardial ischemia 
and irreversible ventricular dysfunction. Independently from the 
presence of coronary artery disease, in the case of hemodynamic 
derangement, if not appropriately managed, cardiac output may 
become irreversibly depressed and cardiac arrest may ensue. 
    Although spinal anaesthesia is not absolutely contraindicated for 
patients with aortic stenosis, these patients are more susceptible 
to the potential hazard of sudden hypotension as a result of the 
reduced systemic vascular resistance caused by the sympathetic 
blockade. Although a ‘target blood pressure value’ to define intra-
operative arterial hypotension has not been universally stated, a 
percentage decreases > 20% in mean arterial pressure, or mean 
arterial pressure values < 60 mmHg for cumulative durations of 
30 minutes, is associated with a an elevated risk of post-operative 
myocardial infarction, stroke, and death. The use of invasive 
arterial monitoring in order to provide beat-to-beat measurement 
and enable rapid correction of hypotension is essential to avoid 
potential irreversible hemodynamic derangement. 
GUIDELINES 
The current American College of Cardiology/American Heart 
Association and European Society of Cardiology guidelines[2,3] 
consider patients with severe, asymptomatic aortic stenosis (AS) at 
elevated risk for non-cardiac surgery. Therefore they should have 
elective non-cardiac surgery postponed or cancelled. Aortic valve 
replacement is suggested before elective but necessary non-cardiac 
surgery. Transcatheter valve implantation may be a reasonable 
alternative in high risk patients with serious co-morbidities[6]. Per 
cutaneous balloon aortic valvuloplasty may be both a bridge to 
non-cardiac surgery in hemodynamically unstable adult patients 
with aortic stenosis who refuse or are at high risk for aortic valve 
replacement surgery or need urgent non-cardiac surgery[7]. 
    However these recommendations are based on few, non recent, 
small observational studies. In patients with severe aortic stenosis 
who refuse cardiac surgery or are otherwise not candidates for 
aortic valve replacement, was reported a mortality risk associated 
with non-cardiac surgery close to 10%[4,8]. 
    The optimal management of asymptomatic patients with severe 
AS is even more controversial, with few available data to determine 
the best clinical approach. There have been only a few observational 
studies that have examined the impact of severe AS on the 
postoperative outcomes in patients undergoing NCS According to 
guidelines low to intermediate risk surgery, including orthopaedic 
surgery, can be safely performed in asymptomatic patients. Since 
major orthopaedic surgery (elective hip or knee replacement or 
surgery for hip fracture) is not uncommonly associated with high 
blood losses that may critically impair hemodynamic in AS should 
we consider it effectively an intermediate risk surgery? In high 
risk patients not candidate for aortic valve replacement or TAVI, 
elective surgery under strict haemodynamic monitoring should be 
performed only if strictly needed.
ELECTIVE SURGERY 
As previously reported in the case of elective non-cardiac surgery, 
the presence of symptoms has been considered a key for decision 
making. In symptomatic patients, aortic valve replacement should 
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be considered before elective surgery. In patients who are not 
candidates for valve replacement either due to high risks associated 
with serious co-morbidities or those who refuse, non-cardiac 
surgery should be performed only if is essential. However current 
guidelines are based on limited and dated studies. 
    A small study published in 1987[9] reported the perioperative course 
of 48 (mean age, 73 years, 36 symptomatic) consecutive patients with 
significant aortic stenosis who underwent a non-cardiac operation or 
diagnostic procedure. At Doppler echocardiography average peak 
instantaneous gradient was 76 mmHg and a calculated aortic valve 
area of 0.61 cm2. Seven patients (14%) had one or more transient 
perioperative events, including intraoperative hypotension in five. No 
intraoperative deaths occurred. 
    Similarly a retrospective chart audit of all patients with AS (55 
patients 32 male, 23 female, mean age 73 yr, mean aortic valve area 
0.9 cm2) who underwent non-cardiac surgery in Hamilton between 
1992 and 1994 did not show difference in the risk of cardiac 
complications compared with matched controls[10]. The study 
demonstrated however differences in perioperative  management 
between patients with aortic stenosis and controls. 
    In the study by Torsher et al[11] studied 19 patients with severe AS 
(aortic valve area index < 0.5 cm2/m2 or mean gradient > 50 mmHg 
underwent 28 surgical procedures: 22 elective and 6 emergency. 
The type of anesthesia was general in 26 procedures and continuous 
spinal in 2. Intraarterial monitoring of blood pressure was used in 
20 of the 28 surgical procedures. The anesthesia team was aware 
of the severity of the AS and integrated this into the anesthetic 
plan. Two patients (elective operation in 1 and emergency in 1) had 
complicated postoperative courses and died. There were no other 
intraoperative or postoperative events. 
    Kertai et al[12] studied 108 patients with moderate (mean gradient, 
25 to 49 mmHg) or severe (mean gradient, > or = 50 mmHg) 
aortic stenosis and 216 controls who underwent non-cardiac 
surgery between 1991 and 2000. The main outcome measure was 
the composite of perioperative mortality and nonfatal myocardial 
infarction. The composite end-point was significantly more frequent 
in patients with aortic stenosis (14% [15/108] vs 2% [4/216], P 
< 0.001). Severe aortic stenosis were more commonly followed 
by perioperative complications compared with moderate aortic 
stenosis (31% [5/16] vs 11% [10/92], P = 0.04). After adjusting for 
cardiac risk factors, aortic stenosis remained a strong predictor of 
the composite endpoint (odds ratio = 5.2; 95% confidence interval: 
1.6 to 17.0).
    In a recent paper Agarwal et al[4] studied the outcome in patients 
with aortic stenosis undergoing non-cardiac surgery compared to a 
matched control group. AS was classified moderate (valve area: 1.0-
1.5 cm2) or severe (valve area: < 1.0 cm2). Patients were included 
in the study if they had a preoperative echocardiogram within 90 
days before undergoing NCS. Dobutamine stress echocardiography 
was used to identify AS in low flow-low gradient patients. 4 
matched control patients without AS for each patient with AS 
undergoing NCS were identified using propensity score matching. 
The propensity score matching used the 6 revised cardiac risk index 
criteria, in addition to age and sex. A composite of 30-day mortality 
and postoperative myocardial infarction was considered as primary 
outcome. 
    Twenty-nine patients underwent urgent surgery. The reason for 
non adherence to Guidelines suggesting AVR (or TAVI ) in 79% 
undergoing elective surgery are reported in Table 1.
    634 patients with AS undergoing NCS were matched to 2536 
controls. 244 patients had severe AS and 390 patients moderate AS. 
Thirty-day mortality was 2.1% for AS patients compared with 1.0% 
in non-AS controls (P = 0.036). Postoperative myocardial infarction 
was more frequent in patients with AS compared with controls (3.0% 
vs 1.1%; P = 0.001). Combined primary outcome was significantly 
worse for both moderate and severe AS patients compared with 
respective controls (4.4% vs 1.7%; P = 0.002; and 5.7% vs 2.7%; 
P = 0.02, respectively). High-risk surgery, symptomatic severe AS, 
coexisting mitral regurgitation, and preexisting coronary disease 
were significant predictors of primary outcome in patients with AS. 
30-day mortality rate although lower in the severe AS group (1.6%) 
in comparison to moderate AS group (2.3%) was not statistically 
different. In comparison with the non-AS group (2.7%), the incidence 
of primary outcome was significantly higher in the symptomatic 
severe AS group (8.3%; P = 0.007). This difference was largely 
attributable to the higher incidence of postoperative MI. In severe AS 
incidence of coronary artery disease (71.4%) was significantly higher 
among patients experiencing primary outcome in comparison with 
those without the primary outcome (40.4%; P = 0.02). Patients with 
primary outcome and moderate AS had more frequently depressed 
LV ejection fraction < 40% (35.3%) and moderate or severe mitral 
regurgitation (29.4%) as compared with those without the primary 
outcome. These results suggest that patients with moderate AS and 
high risk features like depressed ejection fraction, a greater degree 
of stenosis, or coexisting mitral regurgitation were more prone to 
developing primary outcome as compared with others without high-
risk features. In conclusion the authors state that although AS is 
considered an high risk preoperative risk factor, prognosis is not 
significantly worse than in matched control in elective non-cardiac 
surgery. 
    In a study form the Danish Health Care System 2823 patients 
with AS were compared to 2823 matched controls[13]. 1722 subjects 
in each group underwent elective non-cardiac surgery. 30 day 
mortality has been 3.8% in AS patients in comparison to 2.9% 
in controls, a non-statistically significant difference. Similarly 
MACE was not different in the two groups. Of particular relevance 
was the similar rate of complications between symptomatic and 
asymptomatic patients. 
EMERGENCY-URGENCY SURGERY 
In the case of urgent non-cardiac surgery guidelines suggest that 
in patients with severe AS, such procedures should be performed 
under close haemodynamic monitoring. Few studies reported 
the results of emergency surgery in patients with AS. In the 
investigation by Andersson et al[13] among 2823 patients 40% 
underwent emergency surgery. Overall mortality in AS patients 
was significantly higher (21.4%) than in elective surgery (3.8%) 
However the difference was significantly lower in patients with AS 
undergoing emergency surgery and matched controls (21 vs 17%, 
p < 0.01). Symptomatic patients had a two folds risk of death in 
comparison to asymptomatic.
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    Although near 30% of patients included in the study by Agarwald 
et al[4] underwent urgent surgery, results are not reported separately 
therefore we have no information regarding the risk related to 
different types of surgery in AS patients.
    Among common emergency non-cardiac surgical procedures 
treatment of hip fracture has a prominent epidemiological role. 
Since the incidence of severe aortic valve stenosis in patients who 
need surgery for hip fracture is comprised between 5 and 10%[14] 
and that in Italy every year at least 70 000 patients undergo surgery 
for hip fracture, it may be estimated that between 3 500 and 7 000 
of them suffer from severe aortic stenosis. Despite the “epidemic” 
relevance of this situation only few studies examined the prognostic 
role of aortic stenosis on hospital and mid-term survival in in this frail 
group of patients. The main concern in patients with hip fracture is 
that the diagnosis is frequently omitted since only few centres have 
the availability of bed side echocardiography service to evaluate and 
confirm the severity of AS in patients with systolic murmurs. SIGN 
guidelines in 2009[15] suggested that echocardiography ‘‘should be 
performed if aortic stenosis is suspected, to allow confirmation of 
diagnosis, risk stratification and any future cardiac management’’. 
However, they state that the need for echocardiography ‘‘should 
not delay surgery unduly’’ and that if delays are to be avoided, 
‘‘rapid access to an echocardiography service is recommended’’. 
The cost of setting up and maintaining such a service may be offset 
by reducing delays and improving outcomes. Nevertheless despite 
these recommendations only a negligible proportion of patients 
with hip fracture undergo pre operative echocardiography. 
    Pellikka et al[16] reported that surgery may not pose any additional 
risks for patients with aortic stenosis. Other authors reported a 
trend towards general anaesthesia versus spinal anaesthesia in hip 
fracture patients with varying severity of aortic stenosis; invasive 
monitoring was also used in some patients. A warning to the 
surgeon of high patient cardiac risk may prompt more efficient 
surgery and less blood loss and consideration of less invasive 
techniques.
    Adunsky et al[17] reported a two-fold increase of in hospital 
mortality (6.5 vs 3.2 %) in aortic stenosis (average aortic valve area 
0.97 cm2) in comparison to patients without aortic stenosis.
    Recently Keswani et al[18] in a retrospective case-control study 
in patients with hip fracture compared 65 subjects with aortic 
stenosis to 129 matched controls. Both cardiac and non-cardiac 
complications were significantly more frequent in AS patients 
than in controls. Moreover both 30 day and 1 year mortality were 
significantly higher in AS group (14.7 % vs 4.2 % at 30 days and 
46.8 vs 14.1 % at 1 year respectively). Moderate/severe aortic 
stenosis and chronic kidney disease were the only independent 
predictors of 1 year mortality. In the study of Mc Brien et al[19] 
272 patients with hip fracture and previously undiagnosed AS 
were compared to 3698 patients with hip fracture and no AS. 
Patients with severe AS were more frequently treated in general 
anesthesia (66.7%) and had arterial line positioning for continuous 
Table 1 Reason for non adherence to Guidelines suggesting AVR in 
patients with AS undergoing non cardiac surgery.
Table 2 Comparison in mortality between patients with and without AS 
undergoing Surgery for hip fracture.
The categories are not mutually exclusive. A single patient may belong to 
several categories.
*Unpublished data.
Advanced age 27%
Cancer surgery 12%
Low risk surgery 15%
Multiple comorbidities 51%
Patient refusal  3%
Spinal anesthesia  8%
Tolerated recent surgery 20% 
Mortality Moderate/severe AS Controls
Adunski et al In hospital 6.50% 3.2%
Mc Brien et al  30 day 16.20% 7.40%
1 year 58,6% 22.20%
Kesami et al 30 day 14.70% 4.20%
1 year 48.80% 14.10%
Rostagno* In hospital 7.50% 2.80%
hemodynamic monitoring. Thirty day mortality was 10% in AS in 
comparison to 6.25% in moderate AS and 7.4% in control group, 
while at 1 year mortality in the three groups were 36.7%, 21.9% 
and 22.2% respectively. Time from trauma to surgery was not 
significantly different in patients undergoing echocardiography for 
diagnosis of AS and control patients (average 5 days). Preliminary 
data from our institution about 54 consecutive patients referred for 
hip fracture between 2012 and 2014 and diagnosed moderate/severe 
AS show a 7.5% in hospital mortality in comparison to 2.8% of 
patients without AS (Table 2). 
CONCLUSION
Advances in surgical and anesthetic techniques (avoidance of 
intraoperative hypotension and treating it aggressively with 
phenylephrine, avoidance of tachycardia with aggressive management 
of intraoperative arrhythmia) with closer perioperative monitoring 
appear to allow non-cardiac elective surgical procedures possible 
with acceptable risk in patients with severe aortic stenosis. A correct 
diagnosis of the severity of aortic stenosis is mandatory in preoperative 
evaluation of patients candidate to non-cardiac surgery. On the basis 
of echocardiographic evaluation, adverse events during non-cardiac 
surgery occurred primarily in patients with an AVA < 0.7 cm2 and 
a mean gradient > 50 mm Hg and normal left ventricular function. 
Although data at present are limited, non-cardiac surgery is associated 
with a poorer outcome also in low-flow low- gradient AS. Dobutamine 
stress echocardiography should be used to identify this high risk 
subgroup. Asymptomatic patients with AS with an AVA > 0.8 cm2, 
and preserved LV systolic function should not be labeled as high risk 
for a non-cardiac surgery. Therefore at least for “asymptomatic severe 
aortic stenosis” patients with preserved LV systolic function and no 
other significant valvular pathology, a reappraisal of the grading of 
the severity of AS in general and reassessment of perioperative risk 
during elective non-cardiac surgery is urgently needed[20]. Samarendra 
and Mangione[20] suggest to label high risk fot non-cardiac surgery AS 
patients with a mean gradient > 45 mmHg, left ventricular systolic 
disfunction, symptoms due to AS, associated mitral regurgitation, 
increase > 18 mmHg in mean gradient during exercise echo stress and 
significant concomitant coronary artery disease. 
    For patients who need urgent/emergency non-cardiac surgery 
at present data are limited and not uniform. AS in these patients 
is often previously undiagnosed and only preoperative careful 
evaluation with echocardiographic examination may reveal its 
presence and severity. AS is usually associated with a higher risk 
of perioperative death and myocardial infarction. Preoperative 
detection of valve disease may lead to change anhestesiologic 
strategy (from spinal to general anesthesia in particular in patients 
with hip fracture) and adoption of close hemodynamic monitoring 
that may limit perioperative complications. 
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